CuraTeQ Biologics receives approval for biosimilar Dazublys from UK's MHRA
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Earlier in July 2025, Dazublys has received the marketing authorisation in the European Union from the European Commission
Terufusion Advanced Infusion Systems combine a smart syringe pump, smart infusion pump, and pump monitoring system software for precise and efficient drug administration
The product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), VASOSTRICT Injection 40 Units per 100 mL and 20 Units per 100 mL of PH Health Limited
Protein L is known as a “superantigen” because it can bind antibodies in unusual ways
This project shall be implemented through incorporation of a new joint venture company in Zambia
The company has improved access to quality healthcare for seniors across both urban and rural areas
Astaxanthin is a powerful antioxidant and red-orange carotenoid pigment found in various aquatic organisms
All 2025 pre-filled syringe doses to be made in Canada, marking a domestic production milestone
Subscribe To Our Newsletter & Stay Updated